Pharmagreen Biotech Stock Price Prediction
| PHBI Stock | USD 0 0.0001 5.88% |
Oversold Vs Overbought
45
Oversold | Overbought |
Using Pharmagreen Biotech hype-based prediction, you can estimate the value of Pharmagreen Biotech from the perspective of Pharmagreen Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharmagreen Biotech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Pharmagreen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharmagreen Biotech after-hype prediction price | USD 0.001159 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharmagreen |
Pharmagreen Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Pharmagreen Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharmagreen Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Pharmagreen Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pharmagreen Biotech Estimiated After-Hype Price Volatility
In the context of predicting Pharmagreen Biotech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharmagreen Biotech's historical news coverage. Pharmagreen Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 13.78, respectively. We have considered Pharmagreen Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pharmagreen Biotech is out of control at this time. Analysis and calculation of next after-hype price of Pharmagreen Biotech is based on 3 months time horizon.
Pharmagreen Biotech Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pharmagreen Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharmagreen Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharmagreen Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.81 | 13.78 | 0.00 | 0.02 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 35.59 |
|
Pharmagreen Biotech Hype Timeline
Pharmagreen Biotech is at this time traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Pharmagreen is forecasted to decline in value after the next headline, with the price expected to drop to 0.001159. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -35.59%, whereas the daily expected return is at this time at 1.81%. The volatility of related hype on Pharmagreen Biotech is about 165360.0%, with the expected price after the next announcement by competition of 0.02. About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Pharmagreen Biotech last dividend was issued on the 2nd of July 2018. The entity had 1:200 split on the 2nd of July 2018. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Pharmagreen Biotech Basic Forecasting Models to cross-verify your projections.Pharmagreen Biotech Related Hype Analysis
Having access to credible news sources related to Pharmagreen Biotech's direct competition is more important than ever and may enhance your ability to predict Pharmagreen Biotech's future price movements. Getting to know how Pharmagreen Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharmagreen Biotech may potentially react to the hype associated with one of its peers.
Pharmagreen Biotech Additional Predictive Modules
Most predictive techniques to examine Pharmagreen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmagreen using various technical indicators. When you analyze Pharmagreen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharmagreen Biotech Predictive Indicators
The successful prediction of Pharmagreen Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharmagreen Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharmagreen Biotech based on analysis of Pharmagreen Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharmagreen Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharmagreen Biotech's related companies.
Story Coverage note for Pharmagreen Biotech
The number of cover stories for Pharmagreen Biotech depends on current market conditions and Pharmagreen Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharmagreen Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharmagreen Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pharmagreen Biotech Short Properties
Pharmagreen Biotech's future price predictability will typically decrease when Pharmagreen Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharmagreen Biotech often depends not only on the future outlook of the potential Pharmagreen Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharmagreen Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 442.3 M | |
| Short Long Term Debt | 219.1 K | |
| Shares Float | 370 M |
Complementary Tools for Pharmagreen Pink Sheet analysis
When running Pharmagreen Biotech's price analysis, check to measure Pharmagreen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagreen Biotech is operating at the current time. Most of Pharmagreen Biotech's value examination focuses on studying past and present price action to predict the probability of Pharmagreen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagreen Biotech's price. Additionally, you may evaluate how the addition of Pharmagreen Biotech to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |